团体森田疗法对肝癌手术治疗患者生活质量的影响

目的探讨团体森田疗法对接受肝癌开腹手术治疗的患者生活质量的影响,为提高其生活质量及身心健康水平提供参考。方法选取在广西壮族自治区南宁市某医院接受手术治疗的肝癌患者170例为研究对象,并随机分为实验组(n=78)和对照组(n=92)。对照组不做心理干预,仅对实验组实施团体森田治疗。使用癌症患者生活质量测定量表(EORTC QLQ-C30)评定两组患者的生活质量,对照组进行第一次评定后间隔两周再次评定,实验组分别于团体森田治疗前和治疗结束后一周进行评定。结果实验组第二次评定的躯体功能(83.41±14.60)分vs.(62.82±31.22)分]、角色功能(81.83±24.70)分vs.(57.24±35.05)分]、情绪功能(75.64±23.13)分vs.(52.17±34.98)分]、认知功能(78.20±22.03)分vs.(57.97±34.54)分]、社会功能(61.32±28.74)分vs.(48.91±35.70)分]和总体健康状况评分(62.92±22.85)分vs.(46.73±29.26)分]均高于对照组第二次评分(P均0.05)。结论团体森田疗法可能有助于提高肝癌手术患者的躯体功能、角色功能、情绪功能、认知功能和社会功能,改善其总体健康状况。

Effect of Morita group therapy on quality of life in liver cancer patients undergoing surgical treatment

Objective To investigate the effect of Morita group therapy on the quality of life of liver cancer patients with open surgery, so as to provide references for improving their quality of life and promoting physical and mental health.Methods A total of 170 patients with liver cancer undergoing surgical treatment in a hospital in Nanning City of Guangxi Zhuang Autonomous Region were selected and randomly divided into two groups. The control group (n=92) received no psychological intervention, while the experimental group (n=78) received Morita group therapy. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Questionnaire (EORTC QLQ-C30) was used to evaluate all patients for two times. The time interval between two assessments in control group was set as two weeks, while the assessment in experimental group was first completed prior to treatment, and one week after intervention.Results In the second assessment, the scores of physical function(83.41±14.60) vs. (62.82±31.22)], role function(81.83±24.70) vs. (57.24±35.05)], emotional function(75.64±23.13) vs. (52.17±34.98)], cognitive function(78.20±22.03) vs. (57.97±34.54)], social function (61.32±28.74) vs. (48.91±35.70)] and overall health status (62.92±22.85) vs. (46.73±29.26)] of experimental group were all higher than those in control group (P<0.05).Conclusion Morita group therapy can ameliorate the overall health status of liver cancer patients undergoing surgery through improving their physical, role, emotional, cognitive and social functions.